<p>The disclosure provides compounds of formula I, including pharmaceutically acceptable salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.</p>
申请公布号
EP2488526(B1)
申请公布日期
2013.07.24
申请号
EP20100771277
申请日期
2010.10.14
申请人
BRISTOL-MYERS SQUIBB COMPANY
发明人
WANG, TAO;PENDRI, ANNAPURNA;ZHANG, ZHONGXING;ZHAI, WEIXU;LI, GUO;GERRITZ, SAMUEL;SCOLA, PAUL MICHAEL;SUN, LI-QIANG;ZHAO, QIAN;MULL, ERIC